Search

Your search keyword '"Azaceta G"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Azaceta G" Remove constraint Author: "Azaceta G"
37 results on '"Azaceta G"'

Search Results

1. Data-driven flow cytometry classification of blast differentiation in older patients with acute myeloid leukemia

3. Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes

5. 64 A retrospective time-dependent comparative analysis of the impact of lenalidomide on outcomes in lower risk MDS with chromosome 5q deletion

9. AML typical mutations (CEBPA, FLT3, and NPM1) identify a high-risk CMML independent of CPSS-Mol classification.

10. Granulomatous dermatitis in the context of chronic myelomonocytic leukemia: More than just reactive infiltrates. An illustrative case report with literature review.

11. Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-X L in multiple myeloma cell lines partially dependent on MCL-1 and in plasma cells from patients.

12. Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis.

13. Granulomatous Dermatitis Heralding Myelodisplastic/Myeloproliferative Neoplasms. Neoplastic or Reactive Cells? A Study of 2 Cases.

14. Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma.

15. Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients.

16. Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance.

17. Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells.

18. Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes.

19. Refining the Breakpoints of Three New Translocations Identified in Myelodysplastic Syndromes.

20. Human NK cells activated by EBV + lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells.

21. Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion.

22. Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis.

23. Granulysin induces apoptotic cell death and cleavage of the autophagy regulator Atg5 in human hematological tumors.

24. Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: review of 5,654 patients with an evaluable karyotype.

25. Iminophosphorane-organogold(III) complexes induce cell death through mitochondrial ROS production.

26. Response to lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2 V617F mutation.

27. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.

28. Successful lipid-complexed amphotericin B treatment of Candida arthritis in a lymphoma patient.

29. Hemorheological profile in chronic venous insufficiency after surgery.

30. Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma.

32. [Hypercoagulability status previous to total hip and knee arthroplasty: the contribution of rheumatoid arthritis].

33. Incidence and clinical manifestations of activated protein C resistance and factor V Leiden in young patients with venous thromboembolic disease in Spain.

35. [Intensive treatment of T-cell-rich B lymphoma].

36. [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].

37. [Allo- and autoantibody in a case of autoimmune hemolytic anemia associated with a myelodysplastic syndrome].

Catalog

Books, media, physical & digital resources